Cargando…
Recent Advances and Therapeutic Options in Lambert-Eaton Myasthenic Syndrome
Lambert-Eaton Myasthenic Syndrome (LEMS) is an autoimmune-mediated neurological disorder that manifests as muscle fatigue, diminished tendon reflexes, with symptoms of cholinergic overactivity. It can be associated with certain neoplastic conditions, the most common being small cell lung carcinoma (...
Autores principales: | Anwar, Arsalan, Saleem, Sidra, Ahmed, Mirza Fawad, Ashraf, Sara, Ashraf, Sameen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799875/ https://www.ncbi.nlm.nih.gov/pubmed/31637147 http://dx.doi.org/10.7759/cureus.5450 |
Ejemplares similares
-
Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022) -
Lambert-Eaton Myasthenic Syndrome in Lung Cancer
por: Wang, Yongbin, et al.
Publicado: (2022) -
Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
por: Bukhari, Sumera, et al.
Publicado: (2017) -
Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine
por: Lindquist, Sabine, et al.
Publicado: (2011) -
Lambert-Eaton Myasthenic Syndrome; Pathogenesis, Diagnosis, and Therapy
por: Gilhus, Nils Erik
Publicado: (2011)